Tofacitinib’s standard usage and dosage and medication precautions

Tofacitinib is an oral small molecule JAK inhibitor mainly used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Its standard usage, dosage and medication precautions are crucial to ensure efficacy and safety. The following is a detailed description.

1. Standard usage and dosage

The specific dosage of tofacitinib varies according to different indications and usually needs to be adjusted individually under the guidance of a doctor.

1.Rheumatoid arthritis: The usual dosage for adult patients is 5mg orally twice a day. For patients with more severe disease or an inadequate response to the initial dose, doctors may consider adjusting the dose to 10 mg twice daily, but high doses are generally not recommended for long-term use.

2.Psoriatic Arthritis: The standard dose is 5mg taken orally twice daily. The dosage may be adjusted based on the patient's response to treatment.

3.Ulcerative colitis: The starting dose is usually 10 mg twice a day. After continuous use for 8 weeks, the maintenance dose is adjusted to 5 mg twice a day based on the condition of stable disease.

Tofacitinib should be swallowed whole and can be taken with food or on an empty stomach. The taking time is relatively flexible, but it needs to be maintained regularly to avoid missing doses.

2. Precautions when taking medication

1.Monitor blood indicators

Tofacitinib may cause hematological abnormalities, such as leukopenia, anemia, and thrombocytopenia. Therefore, routine blood tests must be performed regularly during medication to ensure that blood indicators are within a safe range. More frequent monitoring is warranted, especially during the initial stages of treatment and during dose adjustments.

2.Infection risk

Since tofacitinib works by suppressing the immune system, patients' immune function declines while taking the drug, which easily increases the risk of infection, especially opportunistic infections such as tuberculosis and herpes zoster. Tuberculosis screening should be carried out before taking the medicine. If infection symptoms such as fever and cough occur, you should seek medical treatment in time. If necessary, stop taking the medicine.

3.Liver function and renal function monitoring

The metabolism of tofacitinib mainly depends on the liver and is partially excreted by the kidneys. Liver and kidney function need to be monitored regularly during medication. If abnormalities are found, the dose should be adjusted or treatment suspended to avoid aggravation of liver and kidney damage.

4.Avoid combination with specific drugs

Tofacitinib may interact with certain drugs, such as enzyme inhibitors or inducers, which will affect its metabolism rate, change drug concentration, and affect efficacy and safety. Patients should inform their doctors about all medications they are taking, including over-the-counter drugs and supplements.

5.Pregnant and lactating women

The safety of tofacitinib on the fetus has not been fully established and pregnant women should avoid its use. Breastfeeding women should also be cautious and decide whether to take medication under the guidance of a doctor after weighing the pros and cons.

3. Other suggestions

While taking tofacitinib, patients should maintain good living habits, strengthen nutrition, avoid fatigue and mental stress, and actively cooperate with doctors for follow-up examinations. If any discomfort or abnormal reaction is discovered, medical staff should be informed promptly. For patients taking medication for a long time, it is recommended to regularly evaluate the treatment effects and adverse reactions, and adjust the treatment plan if necessary.

In summary, tofacitinib is an effective immunomodulatory drug, and the standard usage and dosage must be strictly adhered to the doctor's instructions and reasonably adjusted based on the patient's specific condition. During the medication process, great attention should be paid to blood indicators, infection risks, and liver and kidney function monitoring, and the principles of safe medication should be followed to ensure the safety and effectiveness of treatment. Through standardized medication and scientific management, tofacitinib can bring significant improvement in efficacy and quality of life to patients.

Reference materials:https://www.xeljanz.com/